Barijak 4 Mg Tablets

Product Description

Product introduction

Barijak 4mg Tablet is used in combination with Remdesivir for the treatment of coronavirus disease (COVID-19) in hospitalized adults.

Barijak 4mg Tablet may be prescribed alone or in combination with another drug. It can be taken with or without food, but it is best to take it at the same time each day. Your dose will depend on your condition and what other medicines you are taking. You should use it as your doctor tells you to. Dont stop taking this medicine unless your doctor tells you to because your condition could get worse.

The most common side effects of Barijak 4mg Tablet include throat and nose infections, nausea, and viral infection. You may also get cold sores, feel sick, or have symptoms of a cold, like a stuffy nose, sneezing, and a sore throat. If you have any worries about side effects, talk to your doctor.

Before starting Barijak 4mg Tablet, your doctor may advise blood tests, and you should not take Barijak 4mg Tablet if you have an active infection. Inform your doctor if you ever have tuberculosis, shingles, kidney or liver disease, hepatitis B or C, or blood clots in your legs or lungs.

Barijak 4mg Tablet can increase your risk of infections or worsen existing ones, so avoid contact with people who have contagious illnesses like chickenpox, measles, or flu. This medicine is not suitable for children under 18 years old. If you are pregnant or breastfeeding, use it only if your doctor believes the benefits outweigh the risks. Regular check-ups with your doctor may be necessary while on this treatment.

Comprehensive Immunomodulation for Rheumatoid Conditions

Barijak 4 mg Tablets provide targeted immunomodulatory action through Baricitinib, a Janus kinase inhibitor, offering effective management for adults with rheumatoid arthritis. By modulating specific immune pathways, Barijak helps reduce inflammation and joint damage. Its efficacy also extends, when prescribed by healthcare professionals, to support treatment in specific COVID-19 cases, reinforcing its role in advanced therapy for critical inflammatory conditions.


Simple Oral Administration with Flexible Guidelines

Barijak is supplied in easy-to-swallow, film-coated tablets that can be taken orally with or without food, making daily administration convenient for adults. Dosage and duration are strictly based on the physician's advice, ensuring personalized treatment. Each pack contains 30 tablets, clearly labeled and designed for user safety and responsible use. Proper adherence to dosage and medical instructions ensures optimum therapeutic outcomes.


Safety and Storage Recommendations

For best results, store Barijak below 30C in its original packaging, away from moisture and direct sunlight. Patients should follow medical guidance closely, particularly due to possible side effects such as nausea, headache, or increased vulnerability to infections. This medication is not recommended during pregnancy or breastfeeding, and monitoring is necessary for any signs of infection during use. Always handle and store Barijak responsibly.